Literature DB >> 5147266

Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice.

R Yanai, H Nagasawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5147266     DOI: 10.1007/BF02135754

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  4 in total

1.  Recent studies of the hormonal influence in mouse mammary tumorigenesis.

Authors:  H A BERN; S NANDI
Journal:  Prog Exp Tumor Res       Date:  1961

2.  Estrous cycle of mouse with subcutaneous pellet implant of ergocornine and 2-Br-alpha-ergokryptin.

Authors:  H Nagasawa; R Yanai
Journal:  Endocrinol Jpn       Date:  1970-06

3.  Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.

Authors:  R Yanai; H Nagasawa
Journal:  J Natl Cancer Inst       Date:  1970-12       Impact factor: 13.506

4.  Enhancement by hypophyseal hormones on the malignant transformation of transplanted hyperplastic nodules of the mouse mammary gland.

Authors:  A Dux; O Mühlbock
Journal:  Eur J Cancer       Date:  1969-05       Impact factor: 9.162

  4 in total
  3 in total

1.  Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.

Authors:  L Varga; P M Lutterbeck; J S Pryor; R Wenner; H Erb
Journal:  Br Med J       Date:  1972-06-24

2.  Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat.

Authors:  C W Welsch; G Louks; D Fox; C Brooks
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

3.  Plasma lipids and prolactin in patients with breast cancer.

Authors:  I A Bani; C M Williams; P S Boulter; J W Dickerson
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.